Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer

Clinical trial NCT05961124 · RECRUITING

Trial details

NCT number: NCT05961124
Sponsor: Sunnybrook Health Sciences Centre
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Stage III Ovarian Cancer Stage IV Ovarian Cancer High Grade Ovarian Serous Adenocarcinoma

Start date: 2023-08-21
Primary completion: 2025-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.